Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
130.14%
-
Total 13F principal
-
$423,191,262
-
Principal change
-
-$13,247,460
-
Total reported market value
-
$550,968,500
-
Number of holders
-
44
-
Value change
-
-$22,857,744
-
Number of buys
-
20
-
Number of sells
-
19
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q1 2016
As of 31 Mar 2016,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
44 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$423,191,262
in principal (par value) of the bond.
The largest 10 bondholders included
ZAZOVE ASSOCIATES LLC, Allianz Asset Management AG, WELLS FARGO & COMPANY/MN, AXA, VICTORY CAPITAL MANAGEMENT INC, ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, PRUDENTIAL PLC, CSS LLC/IL, and Invesco Ltd..
This page lists
44
institutional bondholders reporting positions
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.